Biloxi Hma LLC
Biloxi Hma LLC was paid $25.71M by Medicaid between Jan 2018 and Dec 2024, across 240 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.
BILOXI, MS 39530
Next to other General Acute Care Hospital providers in Mississippi
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 112,507 | $3.91M | |
| 2019 | 109,256 | $4.18M | |
| 2020 | 86,107 | $3.05M | |
| 2021 | 104,539 | $3.90M | |
| 2022 | 118,872 | $4.01M | |
| 2023 | 124,657 | $4.13M | |
| 2024incomplete | 71,321 | $2.53M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 34,350 | 26,581 | $4.43M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 20,125 | 15,581 | $3.49M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 8.1% | 4,742 | 4,069 | $2.08M |
| G0378 | Hospital observation service, per hour | 4.7% | 4,182 | 2,382 | $1.22M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.6% | 5,740 | 4,459 | $1.17M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.7% | 11,463 | 8,541 | $963K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.7% | 7,775 | 6,100 | $960K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 8,589 | 7,116 | $702K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.0% | 9,675 | 2,054 | $527K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 2,902 | 2,382 | $504K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.9% | 10,736 | 8,775 | $498K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.9% | 5,686 | 3,777 | $493K |
228 more codes
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.5% | 669 | $387K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 10,836 | $380K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.4% | 3,855 | $358K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 12,532 | $345K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 7,443 | $327K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 7,707 | $317K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 8,000 | $314K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 9,249 | $313K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.2% | 3,243 | $308K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 13,732 | $280K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,925 | $256K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 5,980 | $241K |
| 80053 | Comprehensive metabolic panel | <1% | 29,378 | $210K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 15,347 | $210K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,663 | $207K |
| 88312 | <1% | 5,227 | $176K | |
| 86900 | <1% | 4,662 | $176K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 32,695 | $176K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,568 | $168K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 5,633 | $154K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 10,284 | $150K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 879 | $132K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,730 | $128K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,730 | $127K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 10,805 | $124K |
| 36415 | Collection of venous blood by venipuncture | <1% | 51,374 | $112K |
| 74018 | <1% | 2,006 | $90K | |
| 86850 | <1% | 4,546 | $77K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 1,197 | $75K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,021 | $72K |
| 59025 | Fetal non-stress test | <1% | 780 | $68K |
| 83880 | <1% | 3,649 | $66K | |
| 87070 | <1% | 9,724 | $65K | |
| 86901 | <1% | 5,043 | $61K | |
| 81025 | <1% | 10,749 | $61K | |
| 84484 | <1% | 8,316 | $58K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,058 | $57K |
| 87420 | <1% | 5,284 | $57K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,597 | $54K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 630 | $52K |
| 88142 | <1% | 3,194 | $50K | |
| 81382 | <1% | 732 | $47K | |
| 73630 | <1% | 1,138 | $45K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 524 | $44K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 876 | $42K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,904 | $42K |
| 88304 | <1% | 866 | $41K | |
| 81376 | <1% | 687 | $40K | |
| 80055 | <1% | 1,088 | $39K | |
| 73610 | <1% | 894 | $39K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,190 | $39K |
| 73562 | <1% | 1,036 | $38K | |
| 87806 | <1% | 2,159 | $38K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 877 | $38K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,271 | $37K |
| 83516 | <1% | 1,663 | $36K | |
| 81003 | <1% | 23,028 | $35K | |
| 84702 | <1% | 3,328 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,781 | $35K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 505 | $32K |
| 87040 | <1% | 3,895 | $31K | |
| 72100 | <1% | 627 | $30K | |
| 83690 | <1% | 6,068 | $28K | |
| 73130 | <1% | 705 | $28K | |
| 73221 | <1% | 197 | $25K | |
| 83735 | <1% | 6,640 | $25K | |
| 85027 | <1% | 4,878 | $24K | |
| 80061 | Lipid panel | <1% | 2,315 | $24K |
| 87186 | <1% | 3,710 | $23K | |
| 92526 | <1% | 371 | $22K | |
| 73030 | <1% | 576 | $21K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 154 | $20K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 450 | $20K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,272 | $19K |
| 82553 | <1% | 3,260 | $18K | |
| 82550 | <1% | 4,722 | $18K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 177 | $18K |
| 84439 | <1% | 2,933 | $17K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 714 | $17K |
| 85730 | <1% | 5,100 | $17K | |
| 73110 | <1% | 412 | $16K | |
| 82077 | <1% | 1,506 | $15K | |
| 87088 | <1% | 2,672 | $14K | |
| 86140 | <1% | 3,795 | $14K | |
| 83605 | <1% | 2,126 | $14K | |
| 85610 | <1% | 5,806 | $14K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,991 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,850 | $12K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 176 | $11K |
| 76641 | <1% | 150 | $10K | |
| 82962 | <1% | 5,877 | $10K | |
| 80143 | <1% | 876 | $9K | |
| 87077 | <1% | 1,751 | $9K | |
| 80179 | <1% | 841 | $9K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 157 | $8K |
| 87427 | <1% | 901 | $8K | |
| 83630 | <1% | 523 | $8K | |
| 83993 | <1% | 511 | $8K | |
| 87899 | <1% | 880 | $8K | |
| 86738 | <1% | 742 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 428 | $8K |
| 82248 | <1% | 1,842 | $7K | |
| 85651 | <1% | 1,762 | $7K | |
| 87147 | <1% | 1,730 | $7K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 134 | $7K |
| 76830 | Ultrasound, transvaginal | <1% | 90 | $7K |
| 86803 | <1% | 824 | $7K | |
| 87045 | <1% | 904 | $7K | |
| 82105 | <1% | 527 | $6K | |
| 82784 | <1% | 877 | $6K | |
| 87428 | <1% | 176 | $6K | |
| 86780 | <1% | 711 | $6K | |
| 87205 | <1% | 1,703 | $6K | |
| 82677 | <1% | 297 | $6K | |
| 85378 | <1% | 1,049 | $6K | |
| 87177 | <1% | 777 | $5K | |
| 78227 | <1% | 15 | $5K | |
| 72141 | <1% | 54 | $5K | |
| 82247 | <1% | 1,290 | $5K | |
| 87081 | <1% | 978 | $5K | |
| 87329 | <1% | 512 | $5K | |
| 12011 | <1% | 46 | $5K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 193 | $5K |
| 82607 | <1% | 389 | $4K | |
| 87324 | <1% | 442 | $4K | |
| 86336 | <1% | 297 | $4K | |
| D2934 | <1% | 36 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 100 | $4K |
| 97116 | <1% | 261 | $3K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 13 | $3K |
| 93971 | <1% | 82 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 36 | $3K |
| 36600 | <1% | 52 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 33 | $3K |
| 84703 | <1% | 565 | $3K | |
| 81002 | <1% | 1,293 | $3K | |
| 82950 | <1% | 679 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,720 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,925 | $2K |
| 73502 | <1% | 84 | $2K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 29 | $2K |
| 92523 | <1% | 12 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,558 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,392 | $2K |
| 72040 | <1% | 41 | $2K | |
| 82947 | <1% | 552 | $2K | |
| 96376 | <1% | 3,105 | $2K | |
| 85007 | <1% | 448 | $1K | |
| 12001 | <1% | 13 | $1K | |
| 29125 | <1% | 23 | $1K | |
| 76801 | <1% | 14 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 16 | $994.34 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,015 | $958.56 |
| 77066 | Tomosynthesis, mammo | <1% | 16 | $941.58 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 663 | $891.33 |
| 82803 | <1% | 53 | $831.52 | |
| 71250 | <1% | 28 | $790.80 | |
| 97162 | <1% | 33 | $784.27 | |
| 77065 | Tomosynthesis, mammo | <1% | 12 | $688.81 |
| 86703 | <1% | 61 | $686.96 | |
| 97010 | <1% | 143 | $565.85 | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | <1% | 2,766 | $563.69 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 10,169 | $562.14 |
| 87210 | <1% | 169 | $557.81 | |
| 82150 | <1% | 170 | $516.00 | |
| 83020 | <1% | 66 | $413.77 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,235 | $395.19 |
| 82728 | <1% | 44 | $381.45 | |
| 83540 | <1% | 87 | $379.71 | |
| 87340 | <1% | 48 | $298.23 | |
| 86592 | <1% | 107 | $262.47 | |
| 84145 | <1% | 642 | $193.62 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | <1% | 50 | $190.00 |
| 82951 | <1% | 18 | $185.94 | |
| 81001 | <1% | 103 | $143.25 | |
| 82565 | <1% | 30 | $116.10 | |
| 84100 | <1% | 35 | $113.20 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 327 | $103.70 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,749 | $101.96 |
| J2704 | Injection, propofol, 10 mg | <1% | 9,685 | $96.78 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,359 | $87.24 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,935 | $85.75 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 347 | $64.76 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,370 | $60.64 |
| 83615 | <1% | 14 | $60.04 | |
| 90714 | <1% | 247 | $59.84 | |
| 82043 | <1% | 13 | $47.43 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,795 | $44.72 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,170 | $24.86 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 297 | $11.35 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 961 | $10.03 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 380 | $9.01 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,383 | $1.32 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,380 | $1.20 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 1,545 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 2,124 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 2,705 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 288 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 318 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 20 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 13 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 96 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 358 | $0.00 |
| J3490 | Unclassified drugs | 0% | 243 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 25 | $0.00 |
| 80320 | 0% | 60 | $0.00 | |
| D0150 | Comprehensive oral evaluation - new or established patient | 0% | 14 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 16 | $0.00 |
| J2805 | Injection, sincalide, 5 micrograms | 0% | 15 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 86 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 41 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 29 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 10,309 | $0.00 |
| 94664 | 0% | 32 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 200 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 16 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 38 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 223 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 46 | $0.00 |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 0% | 15 | $0.00 |
| G1002 | Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program | 0% | 75 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 61 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 14 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 49 | $0.00 |
| 90715 | 0% | 40 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 51 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 15 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Memorial Hospital at Gulfport | Gulfport, MS | $6.18M |
| Memorial Hospital at Gulfport | Gulfport, MS | $5.78M |
| Memorial Hospital at Gulfport | Gulfport, MS | $1.88M |
| Memorial Hospital at Gulfport | Gulfport, MS | $1.71M |
| Memorial Hospital at Gulfport | Wiggins, MS | $1.39M |
| Memorial Hospital at Gulfport | Gulfport, MS | $1.10M |
| Memorial Hospital at Gulfport | Gulfport, MS | $764K |
| Memorial Hospital at Gulfport | Ocean Springs, MS | $736K |
| Memorial Hospital at Gulfport | Gulfport, MS | $482K |
| Memorial Hospital at Gulfport | Biloxi, MS | $286K |
| Memorial Hospital at Gulfport | Gulfport, MS | $205K |
| Memorial Hospital at Gulfport | Gulfport, MS | $143K |
| Memorial Hospital at Gulfport | Long Beach, MS | $115K |
| Memorial Hospital at Gulfport | Wiggins, MS | $78K |
| Memorial Hospital at Gulfport | Diamondhead, MS | $68K |
| Memorial Hospital at Gulfport | Bay St Louis, MS | $64K |
| Memorial Hospital at Gulfport | Diamondhead, MS | $40K |
| Memorial Hospital at Gulfport | Biloxi, MS | $21K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.